EMD Serono, Inc. is a leader in the biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve patients' lives. Focusing on specialized areas including neurodegenerative diseases, fertility, metabolic endocrinology, as well as oncology as an emerging area of expertise, EMD Serono is committed to discovering and developing innovative products that meet unmet medical needs.
CombinatoRx, Incorporated is pioneering the new field of synergistic combination pharmaceuticals. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease.
Charm Sciences is a world leading provider of food safety diagnostic tests custom manufactured to meet an ever-changing global regulatory environment. Over the years, Charm has extended its diagnostic portfolio to include test kits and integrated programs for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end-product microbial assessment, allergen control, and ATP.
U.S. Genomics has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies which include proprietary technologies for extraction of high grade DNA from complex samples, tagging, microfluidics and genomic mapping, address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring.
Triton Systems incubates and co-funds materials-inspired products. Triton Systems is leading applied research and development company dedicated to creating products and processes for the US government and commercial markets. We now have evolved into an integrated applied R&D and product development firm with a technology venturing arm and a global expertise in myriad of markets.
SRU Biosystems is a global provider of novel, label-free, detection tools used in drug discovery and life sciences research. Our patented BIND® technology rapidly analyzes biomolecular interactions of cells, proteins, genomic materials, peptides, antibodies and small molecule compound libraries. BIND technology represents a fundamental advance in the ability to monitor label-free biological interactions with high sensitivity and high throughput.
Network Biosystems, Inc. is the leading provider of the full set of technologies and products for the emerging field of Rapid DNA Analysis (RDA). RDA enables the identification (by fragment sizing or nucleic acid sequencing) of the most informative subset of a given human or pathogen genome, allowing end users to make decisions in real time.
Mersana Therapeutics employs its biodegradable polymer platform (Fleximer®) to create new and better medicines. We are advancing our own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. We also leverage the versatility of Fleximer through partnerships to overcome the safety, efficacy, and delivery challenges of nucleic acids, biologics, and small molecules in numerous therapeutic areas.